A1C Explained: What the Number Measures and What Can Affect It

TLDR

A1C is a blood test that estimates glucose exposure over roughly the previous two to three months. It reports the percentage of hemoglobin with glucose attached. For screening and diagnosis, below 5.7% is considered normal, 5.7% to 6.4% is in the prediabetes range, and 6.5% or higher is in the diabetes range. A diabetes-range result usually needs confirmation unless the clinical presentation is unequivocal. A1C is useful, but it does not reveal glucose spikes, low-glucose episodes, or day-to-day variability. Anemia, blood loss, transfusion, pregnancy, kidney disease, altered red-blood-cell turnover, and some hemoglobin variants can also make it less reliable.

Getting A1C explained properly requires more than matching a percentage to a chart. The number is a long-term marker, not a complete scorecard for daily glucose control. It makes the most sense when interpreted alongside symptoms, medical history, medications, and—when available—blood-glucose meter or continuous glucose monitor data.

A1C explained in plain language

A1C is also called hemoglobin A1C, HbA1c, or glycated hemoglobin. Hemoglobin is the oxygen-carrying protein in red blood cells. Glucose circulating in the blood attaches to some of that hemoglobin. The test measures the percentage that has glucose attached, providing a picture of glucose exposure over about two to three months.

A higher percentage generally indicates greater glucose exposure over that period. Unlike a finger-stick glucose test, which measures glucose at one moment, A1C summarizes a longer interval. That is why clinicians use it both to help screen for or diagnose prediabetes and diabetes and to monitor glucose management in people who already have diabetes.

The result is expressed as a percentage. An A1C of 6%, for example, means that approximately 6% of measured hemoglobin is glycated. It does not mean that blood is 6% glucose, nor does it mean glucose stayed at one constant level.

How to read an A1C result

The standard screening and diagnostic ranges for most nonpregnant adults are straightforward, but their meaning depends on whether the test is being used for diagnosis or ongoing management.

A1C result	Screening or diagnostic interpretation
Below 5.7%	Normal range
5.7% to 6.4%	Prediabetes range
6.5% or higher	Diabetes range

These thresholds are used for screening and diagnosis. A result from 5.7% through 6.4% means glucose exposure is above the normal range but has not reached the diagnostic threshold for diabetes. It is a reason to discuss overall metabolic risk and practical prevention steps, not a prediction that progression is inevitable. Readers in this range may find it useful to review steps that can reduce the risk of progression from prediabetes.

An A1C of 6.5% or higher falls in the diabetes range, but one result is not always enough to establish a diagnosis. In the absence of an unequivocal clinical presentation, a diabetes-range result generally needs to be confirmed with a repeat A1C or another accepted diagnostic test. A clinician may also consider fasting plasma glucose, an oral glucose tolerance test, symptoms, and factors that could affect A1C accuracy.

A1C and estimated average glucose

Estimated average glucose, abbreviated eAG, translates A1C into the milligrams-per-deciliter units commonly used by glucose meters. This can make the percentage easier to understand, but eAG remains an estimate derived from A1C rather than a separate measurement.

A1C	Estimated average glucose
5%	97 mg/dL
6%	126 mg/dL
7%	154 mg/dL
8%	183 mg/dL
9%	212 mg/dL
10%	240 mg/dL

These examples come from the American Diabetes Association’s published relationship between A1C and estimated average glucose. They should not be confused with a fasting result, a post-meal reading, or the average reported by a continuous glucose monitor. Those values are generated in different ways and may not match eAG exactly.

For example, two people could both have an A1C of 7% and an eAG estimate of 154 mg/dL while experiencing very different days. One might stay relatively close to the average. The other might alternate between substantial highs and lows. The A1C percentage alone cannot distinguish those patterns.

Diagnostic thresholds are not the same as treatment goals

The 5.7% and 6.5% thresholds help classify screening and diagnostic results. A treatment goal answers a different question: what range is appropriate for a person who has already been diagnosed and is managing diabetes?

The ADA’s 2026 Standards of Care state that an A1C goal below 7% is appropriate for many nonpregnant adults with diabetes, while emphasizing that goals should be individualized. Readers who want the complete clinical context can consult the ADA Standards on glycemic goals.

Below 7% is therefore not a universal target. An appropriate goal may depend on factors such as the risk of hypoglycemia, other health conditions, treatment burden, pregnancy, and the person’s broader care priorities. A diagnostic cutoff should not be used to set or change an individual treatment plan without clinical guidance.

What A1C cannot show

Averages compress many different readings into one number. That makes A1C convenient, but it also hides information that can matter for symptoms, safety, and treatment decisions.

Meal-related glucose spikes: A1C cannot show how high glucose rises after a particular meal.
Low-glucose episodes: A seemingly acceptable average can coexist with hypoglycemia.
Glucose variability: The test does not show whether glucose is stable or frequently moving between highs and lows.
Time in range: A1C does not reveal how much of the day glucose remains within an agreed target range.
Timing and triggers: It cannot connect a pattern to sleep, physical activity, meals, illness, or medication timing.

ADA guidance evaluates glycemic status with A1C alongside blood-glucose monitoring and continuous glucose monitoring metrics when those tools are appropriate. A glucose meter provides individual readings at selected moments. A CGM collects readings across the day and can reveal trends, variability, time in range, and the timing of highs or lows.

That does not make A1C obsolete. It answers a useful long-term question, while meter and CGM data answer more detailed questions about daily patterns. The most informative approach depends on why glucose is being assessed and what decision needs to be made.

When A1C may be misleading

A1C depends on both glucose exposure and the behavior of red blood cells. Conditions that change red-blood-cell lifespan—or interfere with how hemoglobin is measured—can produce a result that does not accurately represent a person’s glucose pattern.

Circumstances associated with less reliable results include recent blood loss or transfusion, hemolytic anemia, iron-deficiency anemia, erythropoietin treatment, dialysis, kidney or liver disease, pregnancy, and some hemoglobin variants. The direction and size of the effect are not identical in every situation, so a list of possible interferences cannot identify why one individual’s result is unexpectedly high or low.

Red-blood-cell turnover

A1C assumes that red blood cells have a reasonably typical lifespan. If cells are removed from circulation sooner or remain longer than expected, the amount of time available for glucose to attach changes. Recent bleeding, transfusion, hemolysis, and treatments that stimulate red-blood-cell production can therefore complicate interpretation.

Iron deficiency and chronic illness

Iron-deficiency anemia and some kidney or liver conditions may affect A1C through changes in red blood cells, treatment, or measurement. Dialysis and erythropoietin treatment are specifically relevant contexts to tell the clinician interpreting the result.

Pregnancy

Pregnancy changes glucose physiology and red-blood-cell dynamics, and pregnancy-specific testing and treatment considerations may apply. An A1C result during pregnancy should therefore be interpreted by a maternity or diabetes care professional rather than compared casually with a general adult chart.

Hemoglobin variants and laboratory methods

Some inherited hemoglobin variants can interfere with A1C measurement. Whether interference occurs may depend on the assay method used by the laboratory. The NIDDK overview of the A1C test provides additional patient-oriented context about test limitations. If a variant is known or suspected, the clinician and laboratory can determine whether the method is appropriate or whether another way of assessing glucose is needed.

What to do when A1C and glucose readings disagree

A meaningful mismatch is worth discussing rather than assuming either number must be wrong. Bring the A1C report, meter records or CGM summary, medication list, and relevant medical history to the conversation. Details such as recent anemia, bleeding, transfusion, pregnancy, kidney disease, dialysis, or a known hemoglobin disorder may help explain the discrepancy.

A clinician can check whether the daily glucose data cover enough time, whether meter technique or sensor issues need review, and whether A1C could be affected by red-blood-cell or hemoglobin factors. When A1C does not fit glucose readings, CGM patterns, symptoms, or the broader clinical context, the discrepancy may indicate that A1C is not reliable for that person.

It is also sensible to seek clinical interpretation when a result is near a diagnostic threshold, when a first result falls in the diabetes range, or when symptoms suggest substantially high or low glucose. Do not change diabetes medication solely to make the A1C number move; treatment changes need to account for daily patterns and the risk of hypoglycemia.

Frequently asked questions

What is the difference between A1C and a blood-glucose test?

A1C estimates glucose exposure over approximately two to three months. A blood-glucose test measures glucose at a particular moment. The tests answer related but different questions, so they do not need to produce numerically matching results.

Does an A1C of 6.5% automatically confirm diabetes?

It is in the diabetes diagnostic range. If there is no unequivocal clinical presentation, however, the result generally needs confirmation through repeat testing or another accepted diagnostic test.

Can A1C miss glucose spikes or low blood sugar?

Yes. A1C summarizes average exposure and does not directly show post-meal spikes, hypoglycemia, variability, or time in range. Meter or CGM data may reveal patterns hidden by the average.

Why might A1C differ from a CGM average?

A1C is based on glycated hemoglobin, whereas a CGM estimates glucose from sensor readings collected over its reporting period. Differences may reflect the time periods covered, daily glucose patterns, or biological factors that affect red blood cells and A1C. A persistent or substantial mismatch deserves clinical review.

Is an A1C goal below 7% right for everyone with diabetes?

No. The ADA identifies below 7% as an appropriate goal for many nonpregnant adults, not every person. Goals should be individualized according to clinical circumstances, safety, and treatment priorities.

The bottom line

A1C is valuable because it condenses several months of glucose exposure into one familiar percentage. The number can support screening, diagnosis, and ongoing diabetes management, but it should not be treated as a complete picture of glucose health.

Start by asking what the test is being used for: diagnosis or management. Then consider whether the result agrees with symptoms, meter readings, CGM patterns, and medical history. If it falls near a diagnostic threshold, reaches the diabetes range for the first time, or conflicts with other glucose information, the practical next step is to discuss confirmation and interpretation with a qualified clinician.